PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine"

Transcription

1 PACKAGE LEAFLET

2 PACKAGE LEAFLET: INFORMATION FOR THE USER /.../ 2.5 mg orodispersible tablets Desloratadine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What /.../ orodispersible tablet is and what it is used for 2. Before you take /.../ orodispersible tablet 3. How to take /.../ orodispersible tablet 4. Possible side effects 5. How to store /.../ orodispersible tablet 6. Further information 1. WHAT /.../ ORODISPERSIBLE TABLET IS AND WHAT IT IS USED FOR /.../ orodispersible tablet is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms. /.../ orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites). These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes. /.../ orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives. Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep. 2. BEFORE YOU TAKE /.../ ORODISPERSIBLE TABLET Do not take /.../ orodispersible tablet - if you are allergic (hypersensitive) to desloratadine, or any of the other ingredients of /.../ orodispersible tablet, or to loratadine. /.../ 2.5 mg orodispersible tablet is indicated for adults and children (6 years of age and older). Take special care with /.../ orodispersible tablet - if you have poor kidney function. If this applies to you, or if you are not sure, please check with your doctor before taking /.../. Taking other medicines Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. There are no known interactions of /.../ with other medicines.

3 Taking /.../ orodispersible tablet with food and drink /.../ orodispersible tablet does not need to be taken with water or liquid. Additionally, /.../ orodispersible tablet may be taken with or without a meal. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine during pregnancy and breastfeeding. If you are pregnant or nursing a baby, taking /.../ is not recommended. Driving and using machines At the recommended dose, /.../ is not expected to cause you to be drowsy or less alert. However, very rarely some people experience drowsiness, which may affect their ability to drive or use machines. 3. HOW TO TAKE /.../ ORODISPERSIBLE TABLET Before using, carefully peel open the blister and remove the dose of orodispersible tablet without crushing it. Place it in your mouth and it will disperse immediately. Water or other liquid is not needed to swallow the dose. Children 6 to 11 years of age: Take one 2.5 mg /.../ orodispersible tablet once a day. Take the dose immediately after removal from the blister. Adults and adolescents (12 years of age and older): Take two 2.5 mg /.../ orodispersible tablets once a day. Take the dose immediately after removal from the blister. Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take /.../ orodispersible tablets. If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your physician will recommend you a treatment schedule that will depend on the evaluation of the history of your disease. If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your physician may recommend you a longer term treatment. For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your physician. If you take more /.../ orodispersible tablet than you should Take /.../ orodispersible tablet only as prescribed for you. No serious problems are expected with accidental overdose. However, if you take more /.../ orodispersible tablet than you were told to, contact your doctor or pharmacist. If you forget to take /.../ orodispersible tablet If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. Do not take a double dose to make up for forgotten individual doses. 4. POSSIBLE SIDE EFFECTS Like all medicines, /.../ can cause side effects although not everybody gets them. In adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect.

4 During the marketing of desloratadine, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. Cases of palpitations, rapid heartbeat, stomach pain, nausea (feeling sick), vomiting, upset stomach, diarrhoea, dizziness, drowsiness, inability to sleep, muscle pain, hallucinations, seizures, restlessness with increased body movement, liver inflammation and abnormal liver function tests have also been reported very rarely. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE /.../ ORODISPERSIBLE TABLET - Keep out of the reach and sight of children. - Do not store above 25 C. - Store in the original package. - Do not use /.../ orodispersible tablet after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month. - Tell your pharmacist if you notice any change in the appearance of /.../ orodispersible tablet. - Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What /.../ orodispersible tablet contains - The active substance is desloratadine. Each /.../ orodispersible tablet contains 2.5 mg desloratadine. - The other ingredients are: Tablet core: Microcrystalline cellulose, povidone (K-value ), basic butylated methacrylate copolymer, sodium laurilsulfate, dibutyl sebacate, colloidal hydrated silica, dextrates, silicified microcrystalline cellulose, iron oxide red (E172), croscarmellose sodium, sucralose, Tutti frutti, magnesium stearate. What /.../ orodispersible tablet looks like and contents of the pack /.../ 2.5 mg orodispersible tablets are pink, round, flat tablets with a diameter of approximately 6.5 mm. [OPA/Adhesive/(OPA/Aluminium/PVC)] / [CC Kraft Paper/PET/Aluminium/HS lacquer] blisters. The blisters are subsequently packed into cardboard boxes. Pack sizes /.../ 2.5 mg orodispersible tablets: 7, 10, 18, 20, 30, 50, 60 and 90 orodispersible tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Actavis Group PTC ehf. Reykjavíkurvegi Hafnarfjörður Iceland Manufacturer Specifar S.A. 1, 28 Octovriou str., Ag. Varvara Athens Greece

5 This medicinal product is authorised in the Member States of the EEA under the following names: Austria Czech Republic Denmark Finland Hungary Ireland Portugal Desloratadin Actavis 2,5 mg Schmelztabletten Desloratadin Actavis 5 mg Schmelztabletten Desloratadine Actavis 2,5 mg Tablety dispergovatelné v ústech Desloratadine Actavis 5 mg Tablety dispergovatelné v ústech Desloratadin Actavis Smelte tabletter Desloratadine Actavis 2,5 mg tabletti, suussa hajoava Desloratadine Actavis 5 mg tabletti, suussa hajoava Desloratadin Actavis 5 mg szájban diszpergálódó tabletta Desloratadine Actavis 5mg Orodispersible Tablets Desloratadina Actavis This leaflet was last approved in {MM/YYYY}.

6 PACKAGE LEAFLET: INFORMATION FOR THE USER /.../ 5 mg orodispersible tablets Desloratadine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What /.../ orodispersible tablet is and what it is used for 2. Before you take /.../ orodispersible tablet 3. How to take /.../ orodispersible tablet 4. Possible side effects 5. How to store /.../ orodispersible tablet 6. Further information 1. WHAT /.../ ORODISPERSIBLE TABLET IS AND WHAT IT IS USED FOR /.../ orodispersible tablet is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms. /.../ orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites). These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes. /.../ orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives. Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep. 2. BEFORE YOU TAKE /.../ ORODISPERSIBLE TABLET Do not take /.../ orodispersible tablet - if you are allergic (hypersensitive) to desloratadine, or any of the other ingredients of /.../ orodispersible tablet, or to loratadine. /.../ 5 mg orodispersible tablet is indicated for adults and adolescents (12 years of age and older). Take special care with /.../ orodispersible tablet - if you have poor kidney function. If this applies to you, or if you are not sure, please check with your doctor before taking /.../. Taking other medicines Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. There are no known interactions of /.../ with other medicines.

7 Taking /.../ orodispersible tablet with food and drink /.../ orodispersible tablet does not need to be taken with water or liquid. Additionally, /.../ orodispersible tablet may be taken with or without a meal. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine during pregnancy and breastfeeding. If you are pregnant or nursing a baby, taking /.../ is not recommended. Driving and using machines At the recommended dose, /.../ is not expected to cause you to be drowsy or less alert. However, very rarely some people experience drowsiness, which may affect their ability to drive or use machines. 3. HOW TO TAKE /.../ ORODISPERSIBLE TABLET Before using, carefully peel open the blister and remove the dose of orodispersible tablet without crushing it. Place it in your mouth and it will disperse immediately. Water or other liquid is not needed to swallow the dose. Adults and adolescents (12 years of age and older): Take one 5 mg /.../ orodispersible tablets once a day. Take the dose immediately after removal from the blister. Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take /.../ orodispersible tablets. If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your physician will recommend you a treatment schedule that will depend on the evaluation of the history of your disease. If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your physician may recommend you a longer term treatment. For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your physician. If you take more /.../ orodispersible tablet than you should Take /.../ orodispersible tablet only as prescribed for you. No serious problems are expected with accidental overdose. However, if you take more /.../ orodispersible tablet than you were told to, contact your doctor or pharmacist. If you forget to take /.../ orodispersible tablet If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. Do not take a double dose to make up for forgotten individual doses. 4. POSSIBLE SIDE EFFECTS Like all medicines, /.../ can cause side effects although not everybody gets them. In adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect. During the marketing of desloratadine, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. Cases of palpitations, rapid heartbeat, stomach pain, nausea (feeling sick), vomiting, upset stomach, diarrhoea, dizziness, drowsiness, inability to sleep, muscle pain, hallucinations, seizures, restlessness with increased body movement, liver inflammation and abnormal liver function tests have also been reported very rarely.

8 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE /.../ ORODISPERSIBLE TABLET - Keep out of the reach and sight of children. - Do not store above 25 C. - Store in the original package. - Do not use /.../ orodispersible tablet after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month. - Tell your pharmacist if you notice any change in the appearance of /.../ orodispersible tablet. - Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What /.../ orodispersible tablet contains - The active substance is desloratadine. Each /.../ orodispersible tablet contains 5 mg desloratadine. - The other ingredients are: Tablet core: Microcrystalline cellulose, povidone (K-value ), basic butylated methacrylate copolymer, sodium laurilsulfate, dibutyl sebacate, colloidal hydrated silica, dextrates, silicified microcrystalline cellulose, iron oxide red (E172), croscarmellose sodium, sucralose, Tutti frutti, magnesium stearate. What /.../ orodispersible tablet looks like and contents of the pack /.../ 5 mg orodispersible tablets are pink, round, flat tablets with a diameter of approximately 8.0 mm. [OPA/Adhesive/(OPA/Aluminium/PVC)] / [CC Kraft Paper/PET/Aluminium/HS lacquer] blisters. The blisters are subsequently packed into cardboard boxes. Pack sizes /.../ 5 mg orodispersible tablets: 7, 10, 20, 30, 50, 60 and 90 orodispersible tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Actavis Group PTC ehf. Reykjavíkurvegi Hafnarfjörður Iceland Manufacturer Specifar S.A. 1, 28 Octovriou str., Ag. Varvara Athens Greece This medicinal product is authorised in the Member States of the EEA under the following names: Austria Czech Republic Desloratadin Actavis 2,5 mg Schmelztabletten Desloratadin Actavis 5 mg Schmelztabletten Desloratadine Actavis 2,5 mg Tablety dispergovatelné v ústech

9 Denmark Finland Hungary Ireland Portugal Desloratadine Actavis 5 mg Tablety dispergovatelné v ústech Desloratadin Actavis Smelte tabletter Desloratadine Actavis 2,5 mg tabletti, suussa hajoava Desloratadine Actavis 5 mg tabletti, suussa hajoava Desloratadin Actavis 5 mg szájban diszpergálódó tabletta Desloratadine Actavis 5mg Orodispersible Tablets Desloratadina Actavis This leaflet was last approved in {MM/YYYY}.

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine Package leaflet: Information for the patient Desloratadine Actavis 5 mg orodispersible tablets desloratadine Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Grazax 75,000 SQ-T oral lyophilisate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Grazax 75,000 SQ-T oral lyophilisate PACKAGE LEAFLET: INFORMATION FOR THE USER Grazax 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you

More information

1.3.1.3 PACKAGE LEAFLET

1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 1 of 8 1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 2 of 8 Package leaflet: Information for the patient Cefuhexal 250 mg film-coated tablets Cefuhexal 500 mg film-coated

More information

Stugeron 15 mg tablets

Stugeron 15 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Stugeron 15 mg tablets Cinnarizine Stugeron is a registered trademark Read all of this leaflet carefully before you start taking this medicine because it contains

More information

CHLORPHENAMINE. The medicine you have purchased contains chlorphenamine.

CHLORPHENAMINE. The medicine you have purchased contains chlorphenamine. What is in this leaflet CHLORPHENAMINE New Zealand Consumer Medicine Information The medicine you have purchased contains chlorphenamine. This leaflet is intended to provide information on the active ingredient

More information

Valaciclovir generichealth Treatment of zoster and herpes labialis

Valaciclovir generichealth Treatment of zoster and herpes labialis CONSUMER MEDICINE INFORMATION Valaciclovir generichealth Treatment of zoster and herpes labialis contains the active ingredient valaciclovir (hydrochloride) What is in this leaflet This leaflet answers

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Metformine HCl Ceft 500 mg film-coated tablets Metformine HCl Ceft 850 mg film-coated tablets Metformine HCl Ceft 1000 mg film-coated tablets metformin hydrochloride

More information

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

PATIENT INFORMATION LEAFLET. Kopen 250mg Tablets Phenoxymethylpenicillin

PATIENT INFORMATION LEAFLET. Kopen 250mg Tablets Phenoxymethylpenicillin PATIENT INFORMATION LEAFLET Kopen 250mg Tablets Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking your medicine. Keep this leaflet. You may need it again. If you have further

More information

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution Package leaflet: Information for the patient Laxido Orange, powder for oral solution Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen 250mg Tablets PHENOXYMETHYLPENICILLIN

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen 250mg Tablets PHENOXYMETHYLPENICILLIN PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen 250mg Tablets PHENOXYMETHYLPENICILLIN Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER PFIZER Dalacin C 150 mg Capsules clindamycin hydrochloride Dalacin C 150mg Capsules clindamycin hydrochloride PFIZER Read all of this leaflet carefully before

More information

New Zealand Consumer Medicine Information

New Zealand Consumer Medicine Information New Zealand Consumer Medicine Information SINGULAIR montelukast sodium 4 mg, 5 mg & 10 mg tablets What is in this leaflet This leaflet answers some common questions about SINGULAIR. It does not contain

More information

There is a risk of renal impairment in dehydrated children and adolescents.

There is a risk of renal impairment in dehydrated children and adolescents. PACKAGE LEAFLET: INFORMATION FOR THE USER MELFEN 200mg FILM-COATED TABLETS MELFEN 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking this medicine because it

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Famciclovir Teva 250 mg Film-coated Tablets. Famciclovir 125, 250 & 500 mg Film-coated Tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Famciclovir Teva 250 mg Film-coated Tablets. Famciclovir 125, 250 & 500 mg Film-coated Tablets. PACKAGE LEAFLET: INFORMATION FOR THE USER Famciclovir Teva 125 mg Film-coated Tablets Famciclovir Teva 250 mg Film-coated Tablets Famciclovir Read all of this leaflet carefully before you start taking

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSCAR 5 mg film-coated tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSCAR 5 mg film-coated tablets (finasteride) PACKAGE LEAFLET: INFORMATION FOR THE USER PROSCAR 5 mg film-coated tablets (finasteride) This medicine is for use in men only Read all of this leaflet carefully before you start taking this medicine because

More information

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate Package leaflet: Information for the patient Bricanyl Tablets 5 mg terbutaline sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Sibelium 5 mg Tablets flunarizine

Sibelium 5 mg Tablets flunarizine J-C 2015 Sibelium 5 mg Tablets flunarizine PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Valoid 50 mg Tablets (cyclizine hydrochloride)

Valoid 50 mg Tablets (cyclizine hydrochloride) IRL 075-3236-APIL 28032354 Package leaflet: Information for the patient Valoid 50 mg Tablets (cyclizine hydrochloride) Read all of this leaflet carefully before you start taking this medicine because it

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) This medicine is for use in men only Read all of this leaflet carefully before you start to take this medicine.

More information

DOXYLAMINE. Please read this leaflet and the packaging of the medicine you have purchased carefully before you start using doxylamine.

DOXYLAMINE. Please read this leaflet and the packaging of the medicine you have purchased carefully before you start using doxylamine. What is in this leaflet DOXYLAMINE New Zealand Consumer Medicine Information The medicine you have purchased contains doxylamine. This leaflet is intended to provide information on the active ingredient

More information

Package leaflet:information for the user. Zemplar 1 microgram Capsules, Soft Paricalcitol

Package leaflet:information for the user. Zemplar 1 microgram Capsules, Soft Paricalcitol Package leaflet:information for the user Zemplar 1 microgram Capsules, Soft Paricalcitol Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you. leaflet: Information for the user Macrogol 4000 10 g powder for oral solution in sachet Macrogol 4000

More information

Package leaflet: Information for the user. Children s Chesty Coughs 50 mg/5 ml Syrup 6-12 years Guaifenesin

Package leaflet: Information for the user. Children s Chesty Coughs 50 mg/5 ml Syrup 6-12 years Guaifenesin Package leaflet: Information for the user Children s Chesty Coughs 50 mg/5 ml Syrup 6-12 years Guaifenesin. Read all of this leaflet carefully before you start taking this medicine because it contains

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION GRASTEK (Standardized Allergen Extract, Timothy Grass (Phleum pratense) Sublingual Tablets 2800 BAU) This leaflet is part III of a three-part "Product Monograph" published

More information

SANOMIGRAN Tablets 0.5 and 1.5 mg (pizotifen)

SANOMIGRAN Tablets 0.5 and 1.5 mg (pizotifen) Patient Information Leaflet SANOMIGRAN Tablets 0.5 and 1.5 mg (pizotifen) This medicine will usually be referred to just as Sanomigran Tablets in this leaflet. What you need to know about Sanomigran Tablets

More information

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets Package leaflet: Information for the patient Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets Amoxicillin Clavulanic acid Read all of this leaflet carefully before you start

More information

(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol

(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol (NON-PRESCRIPTION) LEAFLET: USER INFORMATION CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol Read all of this leaflet carefully because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. RANITIDINE 150 mg FILM-COATED TABLETS RANITIDINE 300 mg FILM-COATED TABLETS (Ranitidine hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. RANITIDINE 150 mg FILM-COATED TABLETS RANITIDINE 300 mg FILM-COATED TABLETS (Ranitidine hydrochloride) PACKAGE LEAFLET: INFORMATION FOR THE USER RANITIDINE 150 mg FILM-COATED TABLETS RANITIDINE 300 mg FILM-COATED TABLETS (Ranitidine hydrochloride) Read all of this leaflet carefully before you start taking

More information

MAXICLEAR HAYFEVER & SINUS RELIEF

MAXICLEAR HAYFEVER & SINUS RELIEF MAXICLEAR HAYFEVER & SINUS RELIEF Phenylephrine hydrochloride 10 mg & Loratadine 2.5 mg tablets What is in this leaflet This leaflet answers some common questions about MAXICLEAR HAYFEVER & SINUS RELIEF

More information

Package leaflet: Information for the user. Lutinus 100 mg vaginal tablet Progesterone

Package leaflet: Information for the user. Lutinus 100 mg vaginal tablet Progesterone Package leaflet: Information for the user Lutinus 100 mg vaginal tablet Progesterone Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Olanzapine Actavis 5 mg orodispersible tablet Olanzapine Actavis 10 mg orodispersible tablet Olanzapine Actavis 15 mg orodispersible tablet Olanzapine Actavis

More information

What FLUCLOXACILLIN is used for and how it works

What FLUCLOXACILLIN is used for and how it works FLUCLOXACILLIN Flucloxacillin, as the sodium salt What is in this leaflet This leaflet answers some common questions about FLUCLOXACILLIN. It does not contain all the information available on this medicine.

More information

Package Leaflet: Information for the User Zofran melt 4 mg and 8 mg Ondansetron

Package Leaflet: Information for the User Zofran melt 4 mg and 8 mg Ondansetron Novartis (logo) Package Leaflet: Information for the User Zofran melt 4 mg and 8 mg Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Read all of this leaflet carefully because it contains important information for you.

Read all of this leaflet carefully because it contains important information for you. Package Leaflet: Information for the User Thioctacid 600 HR, Film-coated tablets For use in adults Active substance: Alpha-lipoic acid Read all of this leaflet carefully because it contains important information

More information

Package leaflet: Information for the user. Opticrom Single Dose 20 mg/ml Eye Drops, Solution in single-dose container sodium cromoglicate

Package leaflet: Information for the user. Opticrom Single Dose 20 mg/ml Eye Drops, Solution in single-dose container sodium cromoglicate Package leaflet: Information for the user Opticrom Single Dose 20 mg/ml Eye Drops, Solution in single-dose container sodium cromoglicate [For medicines available only on prescription] Read all of this

More information

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride This medicine is for use in men only Read all of this leaflet carefully before you start taking this medicine because

More information

Patient Information SINGULAIR (SING-u-lair) (montelukast sodium) Tablets. SINGULAIR (montelukast sodium) Chewable Tablets

Patient Information SINGULAIR (SING-u-lair) (montelukast sodium) Tablets. SINGULAIR (montelukast sodium) Chewable Tablets Patient Information SINGULAIR (SING-u-lair) Tablets SINGULAIR Chewable Tablets SINGULAIR Oral Granules Read the Patient Information Leaflet that comes with SINGULAIR before you start taking it and each

More information

1. What Malarone is and what it is used for

1. What Malarone is and what it is used for Package leaflet: information for the patient Malarone 250 mg/100 mg film-coated tablets atovaquone/proguanil hydrochloride Read all of this leaflet carefully before you start taking this medicine because

More information

Dadcrome 2% Sterile Eye Drops

Dadcrome 2% Sterile Eye Drops Dadcrome 2% Sterile Eye Drops Sodium Cromoglycate Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have any further questions,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate) Read all of this leaflet carefully before you start taking this medicine because

More information

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist. New Zealand Consumer Medicine Information Antabuse Disulfiram 200mg tablets (die-sul-fear-am) What is in this leaflet? This leaflet answers some common questions about Antabuse. It does not contain all

More information

DK/H/1490/P/001 PACKAGE LEAFLET: INFORMATION FOR THE USER. Lecalpin 10 mg film-coated tablets Lecalpin 20 mg film-coated tablets

DK/H/1490/P/001 PACKAGE LEAFLET: INFORMATION FOR THE USER. Lecalpin 10 mg film-coated tablets Lecalpin 20 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Lecalpin 10 mg film-coated tablets Lecalpin 20 mg film-coated tablets Lercanidipine hydrochloride Read all of this leaflet carefully before you start using this

More information

MALARONE Tablets (250/100) MALARONE Junior Tablets (62.5/25) MALARONE (Atovaquone and Proguanil Hydrochloride)

MALARONE Tablets (250/100) MALARONE Junior Tablets (62.5/25) MALARONE (Atovaquone and Proguanil Hydrochloride) Tablets (250/100) Junior Tablets (62.5/25) (Atovaquone and Proguanil Hydrochloride) Consumer Medicine Information What is in this leaflet? Unless explained differently, the information for "" in this leaflet

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Consumer Medicine Information

Consumer Medicine Information Consumer Medicine Information VALACICLOVIR RBX Valaciclovir 500 mg Tablets What is in this leaflet This leaflet answers some common questions about VALACICLOVIR RBX (valaciclovir). It does not contain

More information

1 What Engerix B is and what it is used for

1 What Engerix B is and what it is used for Package leaflet: Information for the user Engerix B 20 micrograms/1 ml suspension for injection Hepatitis B (rdna) vaccine (adsorbed) (HBV) Read all of this leaflet carefully before you start receiving

More information

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE) Package leaflet: Information for the user Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

[For POM]: Read all of this leaflet carefully before you start using this medicine.

[For POM]: Read all of this leaflet carefully before you start using this medicine. Package Leaflet: Information for the User Duraphat 500mg/100g Toothpaste Active Substance: Sodium Fluoride [For POM]: Read all of this leaflet carefully before you start using this medicine. - Keep this

More information

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets What is in this leaflet This leaflet answers some common questions about JANUVIA. It does not contain all the available information. It does

More information

Non-steroidal Anti-Inflammatory Drugs (NSAIDs)

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Non-steroidal Anti-Inflammatory Drugs (NSAIDs) About your medicine NSAIDs are pain medications used to relieve your pain and inflammation (e.g. swelling, redness and warmth). NSAIDs may be prescribed with

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Mimpara 30 mg film-coated tablets Mimpara 60 mg film-coated tablets Mimpara 90 mg film-coated tablets Cinacalcet Read all of this leaflet carefully before you

More information

Artesunate/amodiaquine 100/270 mg WHOPAR part 3 03/2009, version 1.0 (Sanofi-Aventis) MA058 Section 6 updated : March 2012 PACKAGE LEAFLET

Artesunate/amodiaquine 100/270 mg WHOPAR part 3 03/2009, version 1.0 (Sanofi-Aventis) MA058 Section 6 updated : March 2012 PACKAGE LEAFLET PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER Artesunate Amodiaquine Winthrop 100/270 mg Tablets* -Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Package leaflet: Information for the patient. Donecept 5 mg film-coated tablets Donecept 10 mg film-coated tablets. Donepezil hydrochloride

Package leaflet: Information for the patient. Donecept 5 mg film-coated tablets Donecept 10 mg film-coated tablets. Donepezil hydrochloride Package leaflet: Information for the patient Donecept 5 mg film-coated tablets Donecept 10 mg film-coated tablets Donepezil hydrochloride Read all of this leaflet carefully before you start taking this

More information

B. PACKAGE LEAFLET 21

B. PACKAGE LEAFLET 21 B. PACKAGE LEAFLET 21 Package leaflet: Information for the user Esmya 5 mg tablets Ulipristal acetate Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get

More information

Bisoprolol Fumarate 2.5mg, 5mg & 10mg Tablets

Bisoprolol Fumarate 2.5mg, 5mg & 10mg Tablets Bisoprolol Fumarate 2.5mg, 5mg & 10mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need

More information

Package leaflet: Information for the user. Alfuzosin HCl STADA 10 mg prolonged release tablets Alfuzosin hydrochloride

Package leaflet: Information for the user. Alfuzosin HCl STADA 10 mg prolonged release tablets Alfuzosin hydrochloride Package leaflet: Information for the user Alfuzosin HCl STADA 10 mg prolonged release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before you start taking this medicine because it

More information

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride) Package leaflet: Information for the patient Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride) Read all of this leaflet carefully before you start taking this medicine because it

More information

Prodeine Forte Tablets Paracetamol & Codeine Phosphate Hemihydrate

Prodeine Forte Tablets Paracetamol & Codeine Phosphate Hemihydrate Prodeine Forte Tablets Paracetamol & Codeine Phosphate Hemihydrate CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Prodeine Forte tablets. It does

More information

2 What you need to know before you have Ampiclox

2 What you need to know before you have Ampiclox Reason for update: GDS 14 & QRD Updates Response to questions for variation update section 4.1 of SPC MHRA Submission Date: 6 November 2014 MHRA Approval Date: Text Date: October 2014 Text Issue and Draft

More information

Hydrea 500 mg Hard Capsules Hydroxycarbamide

Hydrea 500 mg Hard Capsules Hydroxycarbamide Package leaflet: Information for the patient Hydrea 500 mg Hard Capsules Hydroxycarbamide Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

SANOMIGRAN Elixir (pizotifen)

SANOMIGRAN Elixir (pizotifen) SANOMIGRAN Elixir (pizotifen) Patient Information Leaflet What you need to know about Sanomigran Elixir Your doctor has decided that you need this medicine to help treat your condition. Please read this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets Metformin hydrochloride Read all of this leaflet carefully before you start taking this

More information

Sudafed Sinus + Anti-inflammatory Pain Relief Caplets Pseudoephedrine Hydrochloride, Ibuprofen

Sudafed Sinus + Anti-inflammatory Pain Relief Caplets Pseudoephedrine Hydrochloride, Ibuprofen Sudafed Sinus + Anti-inflammatory Pain Relief Caplets Pseudoephedrine Hydrochloride, Ibuprofen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Sudafed

More information

Package leaflet: Information for the user Buccastem M Buccal Tablets (PROCHLORPERAZINE MALEATE 3 MG, EQUIVALENT TO 1.85 MG PROCHLORPERAZINE BASE)

Package leaflet: Information for the user Buccastem M Buccal Tablets (PROCHLORPERAZINE MALEATE 3 MG, EQUIVALENT TO 1.85 MG PROCHLORPERAZINE BASE) Package leaflet: Information for the user Buccastem M Buccal Tablets (PROCHLORPERAZINE MALEATE 3 MG, EQUIVALENT TO 1.85 MG PROCHLORPERAZINE BASE) Read all of this leaflet carefully before you start taking

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency

More information

Package Leaflet: Information for the Patient

Package Leaflet: Information for the Patient Package Leaflet: Information for the Patient TERBINAFINE 250mg TABLETS Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide Read all of this leaflet carefully before you start using this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember.

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember. Package leaflet: Information for the user Catacrom 2 % w/v Eye Drops, Solution Sodium cromoglicate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

If you have any concerns about taking this medicine, ask your doctor or pharmacist. EZETROL ezetimibe 10 mg tablet What is in this leaflet This leaflet answers some common questions about EZETROL. It does not contain all the available information. It does not take the place of talking

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Metformin Teva 500 mg Film-coated Tablets Metformin Teva 850 mg Film-coated Tablets metformin hydrochloride Read all of this leaflet carefully before you start

More information

Perfalgan 10 mg/ml, solution for infusion

Perfalgan 10 mg/ml, solution for infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Perfalgan 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. NorLevo 1.5 mg tablet Levonorgestrel

PACKAGE LEAFLET: INFORMATION FOR THE USER. NorLevo 1.5 mg tablet Levonorgestrel PACKAGE LEAFLET: INFORMATION FOR THE USER NorLevo 1.5 mg tablet Levonorgestrel Read all of this leaflet carefully before you start using this medicine. (Statement to be used when product is delivered without

More information

What is in this leaflet. Before you take/give COLDREX PE PHENYLEPHRINE COLD & FLU NIGHT & DAY CAPLETS

What is in this leaflet. Before you take/give COLDREX PE PHENYLEPHRINE COLD & FLU NIGHT & DAY CAPLETS Coldrex PE Phenylephrine Cold & Flu Night & Day Caplets Day caplet - Paracetamol 500 mg, Dextromethorphan Hydrobromide 15 mg, Phenylephrine Hydrochloride 5 mg; Night caplet - Paracetamol 500 mg, Dextromethorphan

More information

JANUMET sitagliptin phosphate/metformin HCl 50 mg/500 mg, 50 mg/850 mg, 50 mg/1000 mg tablets

JANUMET sitagliptin phosphate/metformin HCl 50 mg/500 mg, 50 mg/850 mg, 50 mg/1000 mg tablets JANUMET sitagliptin phosphate/metformin HCl 50 mg/500 mg, 50 mg/850 mg, 50 mg/1000 mg tablets What is in this leaflet This leaflet answers some common questions about JANUMET. It does not contain all the

More information

CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN

CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN Roxithromycin 150 mg and 300 mg tablets What is in this leaflet This leaflet answers some common questions about ARROW - ROXITHROMYCIN. It does not contain

More information

FLIXONASE ALLERGY Non Drowsy Nasal Spray 24 hour Effective Relief and Prevention Available in 60 & 150 sprays

FLIXONASE ALLERGY Non Drowsy Nasal Spray 24 hour Effective Relief and Prevention Available in 60 & 150 sprays FLIXONASE ALLERGY Non Drowsy Nasal Spray 24 hour Effective Relief and Prevention Available in 60 & 150 sprays CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before

More information

Pavacol-D pholcodine PATIENT INFORMATION LEAFLET

Pavacol-D pholcodine PATIENT INFORMATION LEAFLET Pavacol-D pholcodine PATIENT INFORMATION LEAFLET Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly

More information

Hydrocortisyl Skin Ointment 1% Hydrocortisone

Hydrocortisyl Skin Ointment 1% Hydrocortisone PACKAGE LEAFLET: INFORMATION FOR THE USER Hydrocortisyl Skin Ointment 1% Hydrocortisone Is this leaflet hard to see or read? Phone 01 403 5600 for Help. Read all of this leaflet carefully before you start

More information

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP 32 READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Vibramycin Capsules Doxycycline hyclate capsules USP Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

More information

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride Package leaflet: Information for the user Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Lansoprazole 30mg Gastro-Resistant Capsules (Lansoprazole)

Lansoprazole 30mg Gastro-Resistant Capsules (Lansoprazole) Laboratorios Liconsa, S.A. USER PACKAGE LEAFLET: INFORMATION FOR THE Lansoprazole 30mg Gastro-Resistant Capsules (Lansoprazole) Read all of this leaflet carefully before you start taking this medicine.

More information

ZENTEL. Albendazole. Read all of this leaflet carefully before you start taking this medicine.

ZENTEL. Albendazole. Read all of this leaflet carefully before you start taking this medicine. ZENTEL Albendazole Read all of this leaflet carefully before you start taking this medicine. WHAT IS IN THIS MEDICINE Tablet containing 200 mg or 400 mg albendazole. 4 % w/v suspension to be taken orally;

More information

Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)

Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron) Package leaflet: Information for the user Ondemet 4mg and 8mg Tablets (Ondansetron) Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

This leaflet answers some common questions about ARROW - MELOXICAM.

This leaflet answers some common questions about ARROW - MELOXICAM. Arrow - Meloxicam Meloxicam Tablets 7.5mg What is in this leaflet This leaflet answers some common questions about ARROW - MELOXICAM. It does not contain all of the available information. It does not take

More information

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Read this Medication Guide before you start taking EQUETRO and each time you get a refill. There may be new information. This

More information

Package leaflet: Information for the user. Geramox 250 mg and 500 mg Capsules, Hard (amoxicillin)

Package leaflet: Information for the user. Geramox 250 mg and 500 mg Capsules, Hard (amoxicillin) Package leaflet: Information for the user Geramox 250 mg and 500 mg Capsules, Hard (amoxicillin) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

What is the most important information I should know about TREXIMET?

What is the most important information I should know about TREXIMET? PATIENT IMPORTANT SAFETY INFORMATION What is the most important information I should know about TREXIMET? TREXIMET may increase your chance of a heart attack or stroke that can lead to death. TREXIMET

More information

Take special care with Septrin Taking other medicines Taking Septrin with food and drink

Take special care with Septrin Taking other medicines Taking Septrin with food and drink Aspen Logo Package Leaflet: Information for the User Septrin 160 mg/800 mg Forte Tablets co-trimoxazole Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. <invented name> 1 mg Ear drops, solution Ciprofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE USER. <invented name> 1 mg Ear drops, solution Ciprofloxacin PACKAGE LEAFLET: INFORMATION FOR THE USER 1 mg Ear drops, solution Ciprofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

(Ciprofloxacin Hydrochloride Tablets) Apotex Standard 250 mg, 500 mg and 750 mg INFORMATION FOR THE CONSUMER

(Ciprofloxacin Hydrochloride Tablets) Apotex Standard 250 mg, 500 mg and 750 mg INFORMATION FOR THE CONSUMER PR APO-CIPROFLOX (Ciprofloxacin Hydrochloride Tablets) Apotex Standard 250 mg, 500 mg and 750 mg INFORMATION FOR THE CONSUMER This section contains important patient information about APO-CIPROFLOX (ciprofloxacin

More information

MEDICATION GUIDE. ARMODAFINIL (ar moe daf i nil) TABLETS C-IV

MEDICATION GUIDE. ARMODAFINIL (ar moe daf i nil) TABLETS C-IV MEDICATION GUIDE ARMODAFINIL (ar moe daf i nil) TABLETS C-IV Read the Medication Guide that comes with armodafinil tablets before you start taking it and each time you get a refill. There may be new information.

More information

DP-ANASTROZOLE. ANASTROZOLE, 1 mg Film coated tablets. This leaflet answers some of the common questions about DP-ANASTROZOLE.

DP-ANASTROZOLE. ANASTROZOLE, 1 mg Film coated tablets. This leaflet answers some of the common questions about DP-ANASTROZOLE. What is in this leaflet DP-ANASTROZOLE ANASTROZOLE, 1 mg Film coated tablets This leaflet answers some of the common questions about DP-ANASTROZOLE. It does not contain all the information that is known

More information

1. What Olanzapine Tablets is and what it is used for

1. What Olanzapine Tablets is and what it is used for PACKAGE LEAFLET: INFORMATION FOR THE USER Olanzapine 2.5 mg Film-coated Tablets Olanzapine 5 mg Film-coated Tablets Olanzapine 7.5 mg Film-coated Tablets Olanzapine 10 mg Film-coated Tablets Olanzapine

More information

Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride

Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride Read all of this leaflet carefully before you start taking this medicine because it

More information

1 What Amoxil is and what it is used for

1 What Amoxil is and what it is used for Package leaflet: Information for the user Amoxil Paediatric Suspension 125 mg per 1.25 ml amoxicillin Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

CONSUMER MEDICINE INFORMATION NERISONE

CONSUMER MEDICINE INFORMATION NERISONE CONSUMER MEDICINE INFORMATION NERISONE Cream: 1g cream contains 1 mg diflucortolone valerate. Fatty Ointment: 1g fatty ointment contains 1 mg diflucortolone valerate. What is in this leaflet Please read

More information